Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
CRIC
1 other identifier
observational
200
0 countries
N/A
Brief Summary
The objective of this study is to assess the relationship between infusion system colonization (ramps or multi-lumen devices) and the occurrence of CVC infection/colonization. This study is a prospective observational research that does not modify usual patient care. Its objective is to evaluate the relationship between infusion tubing colonization and the occurrence of central venous catheter colonization. The only additional intervention is swabbing the taps at each IV line ramp at systematic ramp changes (done every 4 days) and at catheter removal. For the multi-lumen device, swabbing is only performed upon catheter removal at the level of the one-way valves. After catheter removal, a flush (1 mL of 0.9% NaCl) of the midline is performed and cultured to assess for endoluminal colonization. The distal end of the CVC is sent for culture, following the usual practice of the department to monitor catheter colonization and infections. The primary outcome measure is the proportion of colonized infusion systems based on the culture of the CVC. The secondary objectives are to describe factors associated with CVC infections, to determine the incidence of colonization and infections in different locations of central venous catheters, to analyze the bacterial ecology based on the type of infusion system used, and to evaluate the ecological and economic impact of different devices (ramps vs. multi-lumen devices). The secondary outcome measures are as follows: Proportion of colonized infusion systems based on the colonization status of the CVC and the type of infusion system (ramps vs. multi-lumen devices) Proportion of colonized infusion systems based on the infection status of the CVC and the type of infusion system (ramps vs. multi-lumen devices) Duration of antibiotic treatment Weight of compounds used with each infusion system over the duration of CVC placement (ramps vs. multi-lumen devices) Calculation of material costs based on the infusion system used over the duration of CVC placement (ramps vs. multi-lumen devices)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2023
CompletedFirst Posted
Study publicly available on registry
August 31, 2023
CompletedStudy Start
First participant enrolled
October 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedOctober 6, 2023
August 1, 2023
1 year
May 25, 2023
October 4, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of central venous catheter colonization according to the status colonized or not of the tubing
catheter colonization is defined as a positive culture of the catheter tips ≥ 10p3 CFU/ml and compare the rates in catheter with or without a positive culture of tubiging systems
up to Catheter removal or up to 6 weeks
Secondary Outcomes (4)
Number of days without antibiotics at Day 42 (in the ICU)
up to Catheter removal or up to 6 weeks
Incidence of colonization and infection of central venous catheter according to their site
up to Catheter removal
Incidence of central venous catheter colonization according to the colonization of tubing and to the use or not of a multi lumen device
up to catheter removal or up to 6 weeks
Incidence of central venous catheter infection according to the tubing colonization
up to catheter removal or up to 6 weeks
Eligibility Criteria
All patients admitted in a surgical intensive care unit and requiring a central venous catheter for drug administration
You may qualify if:
- Adults \> 18 years old
- Admitted in Surgical Intensive Care unit
- Requiring a central venous catheter for more than 48h for drug administration (central venous catheter for renal replacement therapy are excluded)
You may not qualify if:
- Patients \< 18 years old
- Patients under legal protection
- Patients who refuse the use of their data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
We will swab the taps at each IV line ramp at systematic ramp changes (done every 4 days) and at catheter removal. For the multi-lumen device, swabbing is only performed upon catheter removal at the level of the one-way valves. After catheter removal, a flush (1 mL of 0.9% NaCl) of the midline is performed and cultured to assess for endoluminal colonization. The distal end of the CVC is sent for culture, following the usual practice of the department to monitor catheter colonization and infections. All these samples will be cultured on agar plates for microbial detection, quantification and identification.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
sigismond lasocki, MD, PhD
CHU Angers, 49033 Angers Cedex 01, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2023
First Posted
August 31, 2023
Study Start
October 23, 2023
Primary Completion
November 1, 2024
Study Completion
January 1, 2025
Last Updated
October 6, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
no plan